0.4063
price up icon6.86%   0.0261
after-market Handel nachbörslich: .41 0.0037 +0.91%
loading

Finanzdaten der Passage Bio Inc-Aktie (PASG)

Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
Enddatum des Zeitraums 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31
Periodenlänge 3 Monate 3 Monate 3 Monate 3 Monate 3 Monate
Operating Income/Loss
2.15%
-18.05
-18.45 -28.67 -25.39 -35.88
Income/Loss From Continuing Operations Before Tax
0.28%
-16.71
-16.76 -27.11 -23.86 -34.34
Income/Loss From Continuing Operations After Tax
0.28%
-16.71
-16.76 -27.11 -23.86 -34.34
Net Income/Loss
0.28%
-16.71
-16.76 -27.11 -23.86 -34.34
Preferred Stock Dividends And Other Adjustments
-
- - - -
Attributable To Noncontrolling Interest
-
- - - -
Basic Average Shares
123.56K%
56.30
0.0455 54.79 54.68 54.62
Diluted Average Shares
123.56K%
56.30
0.0455 54.79 54.68 54.62
Basic Earnings Per Share
0.00%
-0.30
-0.30 -0.49 -0.44 -0.63
Diluted Earnings Per Share
0.00%
-0.30
-0.30 -0.49 -0.44 -0.63
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
-
- - - -
$20.44
price down icon 1.45%
$36.19
price up icon 0.86%
$22.62
price up icon 6.70%
$98.24
price up icon 0.64%
$108.26
price up icon 0.70%
biotechnology ONC
$244.32
price down icon 0.34%
Kapitalisierung:     |  Volumen (24h):